ANTIBIOTIC-ASSOCIATED BLOOD CHANGES IN NEWBORNS
DOI:
https://doi.org/10.21272/eumj.2021;9(4):325-331Keywords:
newborns, antibiotic therapy, complete blood count, cytopeniaAbstract
Objective. The objective of the study was to determine the chances of a decrease in CBC cells when using antibiotics in newborns.
Materials and methods. A total of 46 newborn infants who were hospitalized with the main diagnosis of hypoxic ischemic encephalopathy were examined. By gestational age, they belonged to the late-preterm and term groups. The newborns were divided into 2 subgroups. Group 1 – main group: 25 children who received antibiotics; group 2 – control group: 21 children who did not receive antibiotics. Group 1 was divided into 2 subgroups: Group 1a, 16 newborns who received 1 antibiotic and Group 1b, 9 newborns who received 2 antibiotics. Antibiotics were administered at age-related doses, intravenously, including semi-synthetic penicillins, cephalosporins, aminoglycosides, carbapenems, glycopeptides. The features of the analysis of blood (CBC) were studied.
Results. It was noted that in terms of general characteristics, the newborns of the main and control groups were comparable. When comparing the mean values of blood counts, a significant decrease in erythrocytes, leukocytes and erythrocytes was revealed in the group of newborns who received antibiotics in comparison with the control group. The absolute number of neutrophils was significantly lower in the group of newborns who received 2 antibiotics vs. the control group. The odds ratio calculation showed an increased risk of a decrease in cell levels with antibiotic therapy prescribed. Leukocytes were found to have the greatest chances of decreasing from the normative level – by 5.34 times, as well as erythrocytes – by 3.56 times. The absolute number of neutrophils decreased with the greatest chances when 2 antibiotics were administered – by 22 times.
Conclusions. In general, the antibiotic therapy leads to a decrease in the number of erythrocytes, leukocytes, platelets. This was most noted for leukocytes and erythrocytes. The absolute neutrophil count decreased most significantly with 2 antibiotics used.
Downloads
References
Ree IMC, Fustolo-Gunnink SF, Bekker V, Fijnvandraat KJ, Steggerda SJ, Lopriore E. Thrombocytopenia in neonatal sepsis: Incidence, severity and risk factors. PLoS One. 2017;12(10):e0185581. doi:10.1371/journal.pone.0185581
Hussain K, Salat MS, Mohammad N, et al. Meropenem-induced pancytopenia in a preterm neonate: a case report. J Med Case Reports. 2021;15(1):25. doi:10.1186/s13256-020-02632-1
Goldenberg JZ, Lytvyn L, Steurich J, Parkin P, Mahant S, Johnston BC. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2015;(12):CD004827. doi:10.1002/14651858.CD004827.pub4
Hayes SR, Vargas AJ. Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea. Explore (NY). 2016;12(6):463-466. doi:10.1016/j.explore.2016.08.015
Leger RM, Arndt PA, Garratty G. Serological studies of piperacillin antibodies. Transfusion. 2008;48(11):2429-2434. doi:10.1111/j.1537-2995.2008.01852.x
Madigan T, Banerjee R. Characteristics and outcomes of outpatient parenteral antimicrobial therapy at an academic children’s hospital. Pediatr Infect Dis J. 2013;32(4):346-349. doi:10.1097/INF.0b013e31827ee1c2
Akar A, Singh N, Hyun DY. Appropriateness and safety of outpatient parenteral antimicrobial therapy in children: opportunities for pediatric antimicrobial stewardship. Clin Pediatr (Phila). 2014;53(10):1000-1003. doi:10.1177/0009922813507999
Olson SC, Smith S, Weissman SJ, Kronman MP. Adverse Events in Pediatric Patients Receiving Long-Term Outpatient Antimicrobials. J Pediatric Infect Dis Soc. 2015;4(2):119-125. doi:10.1093/jpids/piu037
Ibáñez L, Vidal X, Ballarín E, Laporte JR. Population-based drug-induced agranulocytosis. Arch Intern Med. 2005;165(8):869-874. doi:10.1001/archinte.165.8.869
George JN, Aster RH. Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. Hematology Am Soc Hematol Educ Program. Published online 2009:153-158. doi:10.1182/asheducation-2009.1.153
Arnold DM, Kukaswadia S, Nazi I, et al. A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia. J Thromb Haemost. 2013;11(1):169-176. doi:10.1111/jth.12052
Murphy JL, Fenn N, Pyle L, et al. Adverse Events in Pediatric Patients Receiving Long-term Oral and Intravenous Antibiotics. Hosp Pediatr. 2016;6(6):330-338. doi:10.1542/hpeds.2015-0069
Christensen RD, Del Vecchio A, Henry E. Expected erythrocyte, platelet and neutrophil values for term and preterm neonates. J Matern Fetal Neonatal Med. 2012;25(Suppl 5):77-79. doi:10.3109/14767058.2012.715472
Henry E, Christensen RD. Reference Intervals in Neonatal Hematology. Clin Perinatol. 2015;42(3):483-497. doi:10.1016/j.clp.2015.04.005
Oka S, Shiragami H, Nohgawa M. Intravascular hemolytic anemia in a patient with antibodies related to meropenem. Intern Med. 2015;54(10):1291-1295. doi:10.2169/internalmedicine.54.3385
Huang R, Cai GQ, Zhang JH, et al. Meropenem-induced immune thrombocytopenia and the diagnostic process of laboratory testing. Transfusion. 2017;57(11):2715-2719. doi:10.1111/trf.14267
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Serhiy V. Popov, Oleksandr I. Smiyan, Olena H. Vasylieva, Liudmyla A. Iusiuk, Anastasiia O. Profatylo, Tetyana V. Romanenko, Dmitro A. Govorun
This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN: 
